Figures & data
Table 1. Concentrations of the stock solutions for the administered doses.
Table 2. Toxicity of the different solvents tested in G. mellonella larvae.
Table 3. Toxicity of the different chemical compounds tested in G. mellonella larvae.
Table 4. Conditions for antimicrobial activity testing in G. mellonella.
Table 5. Conditions for toxicity testing in G. mellonella.
Gu W, Yu Q, Cuixiang Y, et al. In vivo activity of fluconazole/tetracycline combinations in Galleria mellonella with resistant Candida albicans infection. J Global Antimicrob Resist. 2018;13:74–80. pii:S2213-7165(17)30222-9. Aneja B, Irfan M, Kapil C, et al. Effect of novel triazole-amino acid hybrids on growth and virulence of Candida species: in vitro and in vivo studies. Org Biomol Chem. 2016;14:10599. Staniszewska M, Gizinska M, Mikulak E, et al. New 1,5 and 2,5-disubstituted tetrazoles-dependent activity towards surface barrier of Candida albicans. Eur J Med Chem. 2018;145:124–139. Lukowska-Chojnacka E, Mierzejewska J, Milner-Krawczyk M, et al. Synthesis of novel tetrazole derivatives and evaluation of their antifungal activity. Bioorg Med Chem. 2016;24:6058–6065. McCann M, Curran R, Ben-Shoshan M, et al. Silver(I) complexes of 9-anthracenecarboxylic acid and imidazoles: synthesis, structure and antimicrobial activity. Dalton Trans. 2012;41:6516. Desbois AP, Coote PJ. Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents. J Antimicrob Chemother. 2011;66:1785–1790. Tharmalingam N, Jayamani E, Rajamuthiah R, et al. Activity of a novel protonophore against methicillin-resistant Staphylococcus aureus. Future Med Chem. 2017;9:1401–1411. De Lacorte Singulani J, Scorzoni L, de Paula E, et al. Evaluation of the efficacy of antifungal drugs against Paracoccidioides brasilensis and Paracoccidioides lutzii in a Galleria mellonella model. Int J Antimicrob Agents. 2016;48(3):292–297. Betts JW, Hornsey M, Warenham DW, et al. In vitro and in vivo activity of theaflavin-epicatechin combinations versus multidrug-resistant Acinetobacter baumannii. Infect Dis Ther. 2017;6(3):435–442. Palanco AC, Lacorte Singulani J, Costa-Orlandi CB, et al. Activity of 3ʹ-hydroxychalcone against Cryptococcus gattii and toxicity, and efficacy in alternative animal models. Future Microbiol. 2017;12:1123–1134. Browne N, Streciwilk W, Tacke M, et al. Assessment of in vivo antimicrobial activity of the carbene silver(I) acetate derivative SBC3 using Galleria mellonella larvae. Biometals. 2014;27:745–752. Ignasiak K, Maxwell A. Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials. BMC Res Notes. 2017;10:428. Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun. 2005;73(7):3842–3850. Beard RL. Species-specificity of toxicants as related to route of administration. J Econ Entomol. 1949;42:292–300. Beard RL. Chemical activity rations in relation to species-specificity. J Econ Entomol. 1951;44(4):469–471. Zhang K, Ding W, Sun J, et al. Antioxidant and antitumor activities of 4-arylcoumarins and 4-aryl-3,4-dihydrocoumarins. Biochimie. 2014;107:203–230.. PtB Megaw J, Thompson TP, Lafferty RA, et al. Galleria mellonella as a novel in vivo model for assessment of the toxicity of 1-alkyl-3-methylimidazolium chloride ionic liquids. Chemosphere. 2015;139:197–201. Maguire R, Duggan O, Kavanagh K. Evaluation of Galleria mellonella larvae as an in vivo model for assessing the relative toxicity of food preservative agents. Cell Biol Toxicol. 2016;32:209–216. Maguire R, Kunc M, Hyrsl P, et al. Caffeine administration alters the behavior and development of Galleria mellonella larvae. Neurotoxicol Teratol. 2017;64:37–44. Allegra E, Titball RW, Carter J, et al. Galleria mellonella larvae allow the discrimination of toxic and non-toxic chemicals. Chemosphere. 2018;198:469–472.